No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer
Open Access
- 1 October 2017
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 84, 354-359
- https://doi.org/10.1016/j.ejca.2017.07.005
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Surveillance or Adjuvant Treatment With Chemotherapy or Radiotherapy in Stage I Seminoma: A Systematic Review and Meta-Analysis of 13 StudiesClinical Genitourinary Cancer, 2015
- Patterns of Relapse in Patients With Clinical Stage I Testicular Cancer Managed With Active SurveillanceJournal of Clinical Oncology, 2015
- Primum Non Nocere: Active Surveillance for Clinical Stage I Testicular CancerJournal of Clinical Oncology, 2015
- Testicular Cancer — Discoveries and UpdatesThe New England Journal of Medicine, 2014
- Testicular Cancer: A Reflection on 50 Years of DiscoveryJournal of Clinical Oncology, 2014
- One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA groupAnnals of Oncology, 2014
- Active Surveillance Is the Preferred Approach to Clinical Stage I Testicular CancerJournal of Clinical Oncology, 2013
- Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2013
- Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer GroupJournal of Clinical Oncology, 2011
- Prognostic Factors for Relapse in Stage I Seminoma Managed by Surveillance: A Pooled AnalysisJournal of Clinical Oncology, 2002